Abeona Therapeutics Statistics
Total Valuation
ABEO has a market cap or net worth of $352.23 million. The enterprise value is $207.13 million.
| Market Cap | 352.23M |
| Enterprise Value | 207.13M |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, before market open.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ABEO has 57.00 million shares outstanding. The number of shares has increased by 45.39% in one year.
| Current Share Class | 57.00M |
| Shares Outstanding | 57.00M |
| Shares Change (YoY) | +45.39% |
| Shares Change (QoQ) | +2.54% |
| Owned by Insiders (%) | 16.47% |
| Owned by Institutions (%) | 49.11% |
| Float | 36.49M |
Valuation Ratios
The trailing PE ratio is 6.76.
| PE Ratio | 6.76 |
| Forward PE | n/a |
| PS Ratio | 24.22 |
| Forward PS | 4.11 |
| PB Ratio | 2.42 |
| P/TBV Ratio | 2.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 3.13 |
| EV / Sales | 14.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.89, with a Debt / Equity ratio of 0.16.
| Current Ratio | 5.89 |
| Quick Ratio | 5.64 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -25.97 |
Financial Efficiency
Return on equity (ROE) is 70.99% and return on invested capital (ROIC) is -49.66%.
| Return on Equity (ROE) | 70.99% |
| Return on Assets (ROA) | -38.93% |
| Return on Invested Capital (ROIC) | -49.66% |
| Return on Capital Employed (ROCE) | -55.39% |
| Weighted Average Cost of Capital (WACC) | 11.86% |
| Revenue Per Employee | $64,336 |
| Profits Per Employee | $292,642 |
| Employee Count | 226 |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ABEO has paid $102,000 in taxes.
| Income Tax | 102,000 |
| Effective Tax Rate | 0.15% |
Stock Price Statistics
The stock price has increased by +7.48% in the last 52 weeks. The beta is 1.34, so ABEO's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | +7.48% |
| 50-Day Moving Average | 5.60 |
| 200-Day Moving Average | 5.20 |
| Relative Strength Index (RSI) | 67.79 |
| Average Volume (20 Days) | 1,241,339 |
Short Selling Information
The latest short interest is 14.14 million, so 24.81% of the outstanding shares have been sold short.
| Short Interest | 14.14M |
| Short Previous Month | 14.39M |
| Short % of Shares Out | 24.81% |
| Short % of Float | 38.75% |
| Short Ratio (days to cover) | 15.55 |
Income Statement
In the last 12 months, ABEO had revenue of $14.54 million and earned $66.14 million in profits. Earnings per share was $0.91.
| Revenue | 14.54M |
| Gross Profit | -18.01M |
| Operating Income | -92.75M |
| Pretax Income | 66.24M |
| Net Income | 66.14M |
| EBITDA | -90.05M |
| EBIT | -92.75M |
| Earnings Per Share (EPS) | $0.91 |
Balance Sheet
The company has $168.27 million in cash and $23.17 million in debt, with a net cash position of $145.10 million or $2.55 per share.
| Cash & Cash Equivalents | 168.27M |
| Total Debt | 23.17M |
| Net Cash | 145.10M |
| Net Cash Per Share | $2.55 |
| Equity (Book Value) | 144.94M |
| Book Value Per Share | 2.55 |
| Working Capital | 151.94M |
Cash Flow
In the last 12 months, operating cash flow was -$77.73 million and capital expenditures -$7.51 million, giving a free cash flow of -$85.24 million.
| Operating Cash Flow | -77.73M |
| Capital Expenditures | -7.51M |
| Depreciation & Amortization | 2.71M |
| Net Borrowing | -2.22M |
| Free Cash Flow | -85.24M |
| FCF Per Share | -$1.50 |
Margins
Gross margin is -123.84%, with operating and profit margins of -637.92% and 454.86%.
| Gross Margin | -123.84% |
| Operating Margin | -637.92% |
| Pretax Margin | 455.56% |
| Profit Margin | 454.86% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ABEO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -45.39% |
| Shareholder Yield | -45.39% |
| Earnings Yield | 18.78% |
| FCF Yield | -24.20% |
Analyst Forecast
The average price target for ABEO is $19.71, which is 218.93% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.71 |
| Price Target Difference | 218.93% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 222.75% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 5, 2022. It was a reverse split with a ratio of 1:25.
| Last Split Date | Jul 5, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
ABEO has an Altman Z-Score of -2.69 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.69 |
| Piotroski F-Score | 3 |